BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 30067491)

  • 1. Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell-Cell Adhesion Structures.
    Begay RL; Graw SL; Sinagra G; Asimaki A; Rowland TJ; Slavov DB; Gowan K; Jones KL; Brun F; Merlo M; Miani D; Sweet M; Devaraj K; Wartchow EP; Gigli M; Puggia I; Salcedo EE; Garrity DM; Ambardekar AV; Buttrick P; Reece TB; Bristow MR; Saffitz JE; Mestroni L; Taylor MRG
    JACC Clin Electrophysiol; 2018 Apr; 4(4):504-514. PubMed ID: 30067491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies.
    Ortiz-Genga MF; Cuenca S; Dal Ferro M; Zorio E; Salgado-Aranda R; Climent V; Padrón-Barthe L; Duro-Aguado I; Jiménez-Jáimez J; Hidalgo-Olivares VM; García-Campo E; Lanzillo C; Suárez-Mier MP; Yonath H; Marcos-Alonso S; Ochoa JP; Santomé JL; García-Giustiniani D; Rodríguez-Garrido JL; Domínguez F; Merlo M; Palomino J; Peña ML; Trujillo JP; Martín-Vila A; Stolfo D; Molina P; Lara-Pezzi E; Calvo-Iglesias FE; Nof E; Calò L; Barriales-Villa R; Gimeno-Blanes JR; Arad M; García-Pavía P; Monserrat L
    J Am Coll Cardiol; 2016 Dec; 68(22):2440-2451. PubMed ID: 27908349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Filamin C variants are associated with a distinctive clinical and immunohistochemical arrhythmogenic cardiomyopathy phenotype.
    Hall CL; Akhtar MM; Sabater-Molina M; Futema M; Asimaki A; Protonotarios A; Dalageorgou C; Pittman AM; Suarez MP; Aguilera B; Molina P; Zorio E; Hernández JP; Pastor F; Gimeno JR; Syrris P; McKenna WJ
    Int J Cardiol; 2020 May; 307():101-108. PubMed ID: 31627847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Filamin-C variant-associated cardiomyopathy: A pooled analysis of individual patient data to evaluate the clinical profile and risk of sudden cardiac death.
    Celeghin R; Cipriani A; Bariani R; Bueno Marinas M; Cason M; Bevilacqua M; De Gaspari M; Rizzo S; Rigato I; Da Pozzo S; Zorzi A; Perazzolo Marra M; Thiene G; Iliceto S; Basso C; Corrado D; Pilichou K; Bauce B
    Heart Rhythm; 2022 Feb; 19(2):235-243. PubMed ID: 34601126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filamin C in cardiomyopathy: from physiological roles to DNA variants.
    Song S; Shi A; Lian H; Hu S; Nie Y
    Heart Fail Rev; 2022 Jul; 27(4):1373-1385. PubMed ID: 34535832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A CRISPR/Cas9 strategy for the generation of a FLNC knockout hESC line (WAe009-A-70) to model dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy.
    Qin Z; Sun L; Sun X; Su H; Gao X
    Stem Cell Res; 2021 Oct; 56():102562. PubMed ID: 34634758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants.
    Gigli M; Stolfo D; Graw SL; Merlo M; Gregorio C; Nee Chen S; Dal Ferro M; PaldinoMD A; De Angelis G; Brun F; Jirikowic J; Salcedo EE; Turja S; Fatkin D; Johnson R; van Tintelen JP; Te Riele ASJM; Wilde AAM; Lakdawala NK; Picard K; Miani D; Muser D; Maria Severini G; Calkins H; James CA; Murray B; Tichnell C; Parikh VN; Ashley EA; Reuter C; Song J; Judge DP; McKenna WJ; Taylor MRG; Sinagra G; Mestroni L
    Circulation; 2021 Nov; 144(20):1600-1611. PubMed ID: 34587765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutation update for the FLNC gene in myopathies and cardiomyopathies.
    Verdonschot JAJ; Vanhoutte EK; Claes GRF; Helderman-van den Enden ATJM; Hoeijmakers JGJ; Hellebrekers DMEI; de Haan A; Christiaans I; Lekanne Deprez RH; Boen HM; van Craenenbroeck EM; Loeys BL; Hoedemaekers YM; Marcelis C; Kempers M; Brusse E; van Waning JI; Baas AF; Dooijes D; Asselbergs FW; Barge-Schaapveld DQCM; Koopman P; van den Wijngaard A; Heymans SRB; Krapels IPC; Brunner HG
    Hum Mutat; 2020 Jun; 41(6):1091-1111. PubMed ID: 32112656
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Brun F; Gigli M; Graw SL; Judge DP; Merlo M; Murray B; Calkins H; Sinagra G; Taylor MR; Mestroni L; James CA
    J Med Genet; 2020 Apr; 57(4):254-257. PubMed ID: 31924696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ROD2 domain filamin C missense mutations exhibit a distinctive cardiac phenotype with restrictive/hypertrophic cardiomyopathy and saw-tooth myocardium.
    Bermúdez-Jiménez FJ; Carriel V; Santos-Mateo JJ; Fernández A; García-Hernández S; Ramos KA; Piqueras-Flores J; Cabrera-Romero E; Barriales-Villa R; de la Higuera Romero L; Alcalá López JE; Gimeno Blanes JR; Sánchez-Porras D; Campos F; Alaminos M; Oyonarte-Ramírez JM; Álvarez M; Tercedor L; Brodehl A; Jiménez-Jáimez J
    Rev Esp Cardiol (Engl Ed); 2023 May; 76(5):301-311. PubMed ID: 35952944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic variability of filamin C-related cardiomyopathy: Insights from a novel Dutch founder variant.
    Schoonvelde SAC; Ruijmbeek CWB; Hirsch A; van Slegtenhorst MA; Wessels MW; von der Thüsen JH; Baas AF; Stroeks SLVM; Verdonschot JAJ; van der Zwaag PA; Verhagen JMA; Michels M
    Heart Rhythm; 2023 Nov; 20(11):1512-1521. PubMed ID: 37562486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Truncating mutations on myofibrillar myopathies causing genes as prevalent molecular explanations on patients with dilated cardiomyopathy.
    Janin A; N'Guyen K; Habib G; Dauphin C; Chanavat V; Bouvagnet P; Eschalier R; Streichenberger N; Chevalier P; Millat G
    Clin Genet; 2017 Dec; 92(6):616-623. PubMed ID: 28436997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study.
    Augusto JB; Eiros R; Nakou E; Moura-Ferreira S; Treibel TA; Captur G; Akhtar MM; Protonotarios A; Gossios TD; Savvatis K; Syrris P; Mohiddin S; Moon JC; Elliott PM; Lopes LR
    Eur Heart J Cardiovasc Imaging; 2020 Mar; 21(3):326-336. PubMed ID: 31317183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FLNC and MYLK2 Gene Mutations in a Chinese Family with Different Phenotypes of Cardiomyopathy.
    Qin X; Li P; Qu HQ; Liu Y; Xia Y; Chen S; Yang Y; Huang S; Wen P; Zhou X; Li X; Wang Y; Tian L; Hakonarson H; Wu Y; Zhuang J
    Int Heart J; 2021 Jan; 62(1):127-134. PubMed ID: 33455984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of Filamin C Results in Altered Proteostasis, Cardiomyopathy, and Arrhythmias.
    Ohiri JC; Dellefave-Castillo L; Tomar G; Wilsbacher L; Choudhury L; Barefield DY; Fullenkamp D; Gacita AM; Monroe TO; Pesce L; Blancard M; Vaught L; George AL; Demonbreun AR; Puckelwartz MJ; McNally EM
    J Am Heart Assoc; 2024 May; 13(10):e030467. PubMed ID: 38761081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variants in NKX2-5 and FLNC Cause Dilated Cardiomyopathy and Sudden Cardiac Death.
    Sveinbjornsson G; Olafsdottir EF; Thorolfsdottir RB; Davidsson OB; Helgadottir A; Jonasdottir A; Jonasdottir A; Bjornsson E; Jensson BO; Arnadottir GA; Kristinsdottir H; Stephensen SS; Oskarsson G; Gudbjartsson T; Sigurdsson EL; Andersen K; Danielsen R; Arnar DO; Jonsdottir I; Thorsteinsdottir U; Sulem P; Thorgeirsson G; Gudbjartsson DF; Holm H; Stefansson K
    Circ Genom Precis Med; 2018 Aug; 11(8):e002151. PubMed ID: 30354339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA sequencing-based transcriptome profiling of cardiac tissue implicates novel putative disease mechanisms in FLNC-associated arrhythmogenic cardiomyopathy.
    Hall CL; Gurha P; Sabater-Molina M; Asimaki A; Futema M; Lovering RC; Suárez MP; Aguilera B; Molina P; Zorio E; Coarfa C; Robertson MJ; Cheedipudi SM; Ng KE; Delaney P; Hernández JP; Pastor F; Gimeno JR; McKenna WJ; Marian AJ; Syrris P
    Int J Cardiol; 2020 Mar; 302():124-130. PubMed ID: 31843279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel splicing variant in FLNC gene responsible for a highly penetrant familial dilated cardiomyopathy in an extended Iranian family.
    Nozari A; Aghaei-Moghadam E; Zeinaloo A; Mollazadeh R; Majnoon MT; Alavi A; Ghasemi Firouzabadi S; Mohammadzadeh A; Banihashemi S; Nikzaban M; Najmabadi H; Behjati F
    Gene; 2018 Jun; 659():160-167. PubMed ID: 29551499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct molecular signature of phospholamban p.Arg14del arrhythmogenic cardiomyopathy.
    Te Rijdt WP; Asimaki A; Jongbloed JDH; Hoorntje ET; Lazzarini E; van der Zwaag PA; de Boer RA; van Tintelen JP; Saffitz JE; van den Berg MP; Suurmeijer AJH
    Cardiovasc Pathol; 2019; 40():2-6. PubMed ID: 30763825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss-of-Function
    Carruth ED; Qureshi M; Alsaid A; Kelly MA; Calkins H; Murray B; Tichnell C; Sturm AC; ; Baras A; Lester Kirchner H; Fornwalt BK; James CA; Haggerty CM
    Circ Genom Precis Med; 2022 Aug; 15(4):e003645. PubMed ID: 35699965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.